1. Macumber I, Flynn JT. Obesity hypertension: clinical aspects. Pediatric Hypertension. 2023: 405-19. doi:10.1007/978-3-031-06231-5_17

2. Theodoulou A, Hartmann‐Boyce J, Gorenberg J, Oke JL, Butler AR, Bastounis A, et al. Weight regain and mental health outcomes following behavioural weight management programmes: A systematic review with meta‐analyses. Clin Obes. 2023; 13(3): e12575. doi:10.1111/cob.12575 PMid:36623842 PMCid:PMC10909518

3. Voruganti VS. Precision Nutrition: Recent advances in obesity. Physiology (Bethesda). 2023; 38(1) doi:10.1152/physiol.00014.2022 PMid:36125787 PMCid:PMC9705019

4. Liang C, Lee PF, Yeh PC. Relationship between regular leisure-time physical activity and underweight and overweight status in Taiwanese young adults: A cross-sectional study. Int J Environ Res Public Health. 2022; 20(1): 284. doi:10.3390/ijerph20010284 PMid:36612603 PMCid:PMC9819382

5. Park CY, Kim D, Seo MK, Kim J, Choe H, Kim JH, et al. Dysregulation of lipid droplet protein expression in adipose tissues and association with metabolic risk factors in adult females with obesity and type 2 diabetes. J Nutr. 2023; 153(3): 691-702. doi:10.1016/j.tjnut.2023.01.018 PMid:36931749

6. Pérez-López FR, López-Baena MT, Pérez-Roncero GR, Chedraui P, Varikasuvu SR, García-Alfaro P. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis. J Gynaecol Endocrinol. 2023; 39 (1):2152790. doi:10.1080/09513590.2022.2152790 PMid:36480935

7. Marcelin G, Gautier EL, Clément K. Adipose tissue fibrosis in obesity: etiology and challenges. Annu Rev Physiol. 2022; 84(1): 135-55. doi:10.1146/annurev-physiol-060721-092930 PMid:34752708

8. Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: a novel player in metabolic diseases. Front Endocrinol. 2020;11:64. doi:10.3389/fendo.2020.00064 PMid:32153505 PMCid:PMC7045041

9. Lee T, Yun S, Jeong JH, Jung TW. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Mol Cell Endocrinol 2019; 486: 96-104. doi:10.1016/j.mce.2019.03.001 PMid: 30853600

10. Ferahtia A, Halilat MT, Mimeche F, Bensaci E. Surface water quality assessment in semi-arid region (El Hodna watershed, Algeria) based on water quality index (WQI). Studia UBB Chemia. 2021; 66(1): 127-42. doi:10.24193/subbchem.2021.01.10

11. Hussein HK, Aubead NM, Kzar HH, Karim YS, Amin AH, Al-Gazally ME, et al. Association of cord blood asprosin concentration with atherogenic lipid profile and anthropometric indices. Diabetol Metab Syndr. 2022; 14(1): 74. doi:10.1186/s13098-022-00844-7 PMid:35585615 PMCid:PMC9118590

12. Wang CY, Lin TA, Liu KH, Liao CH, Liu YY, Wu VCC, et al. Serum asprosin levels and bariatric surgery outcomes in obese adults. IJO. 2019; 43(5): 1019-25. doi:10.1038/s41366-018-0248-1 PMid:30459402

13. Kerslake R, Sisu C, Panfilov S, Hall M, Khan N, Jeyaneethi J, et al. Differential regulation of genes by the glucogenic hormone asprosin in ovarian cancer. J Clin Med. 2022; 11(19): 5942. doi:10.3390/jcm11195942 PMid:36233808 PMCid:PMC9573256

14. Zou J, Xu C, Zhao ZW, Yin SH, Wang G. Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway. J Transl Med. 2022;20(1):337. doi:10.1186/s12967-022-03542-0 PMid:35902881 PMCid:PMC9331044

15. Camilleri M, Acosta A. Combination Therapies for Obesity. Metab Syndr Relat Disord. 2018; 16(8): 390-4. doi:10.1089/met.2018.0075 PMid:29993319 PMCid:PMC6167613

16. Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol. 2014;10(1): 24-36 doi:10.1038/nrendo.2013.204 PMid:24146030

17. Wang W, Seale P. Control of brown and beige fat development. Nat Rev Mol Cell Biol. 2016; 17(11): 691-702. doi:10.1038/nrm.2016.96 PMid:27552974 PMCid:PMC5627770

18. Huerta-Delgado AS, Roffe-Vazquez DN, Gonzalez-Gil AM, Villarreal-Calderón JR, Tamez-Rivera O, Rodriguez-Gutierrez NA, et al. Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. J Diabetes Res. 2020; 2020: 1949415. doi:10.1155/2020/1949415 PMid:32964051 PMCid:PMC7492943

19. Yamamuro T, Kawabata T, Fukuhara A, Saita S, Nakamura S, Takeshita H, et al. Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy. Nat Commun. 2020;11(1):4150. doi:10.1038/s41467-020-17985-w PMid:32811819 PMCid:PMC7434891

20. Otero-Díaz B, Rodríguez-Flores M, Sánchez-Muñoz V, Monraz-Preciado F, Ordoñez-Ortega S, Becerril-Elias V, et al. Exercise induces white adipose tissue browning across the weight spectrum in humans. Front Physiol. 2018;9:1781. doi:10.3389/fphys.2018.01781 PMid:30618796 PMCid:PMC6297830

21. Cho E, Jeong DY, Kim JG, Lee S. The acute effects of swimming exercise on PGC-1α-FNDC5/irisin-UCP1 expression in male C57BL/6J mice. Metabolites. 2021; 11(2): 111. doi:10.3390/metabo11020111 PMid:33669194 PMCid:PMC7919784

22. Nourshahi M, Mir Khalafzadeh F, Khodagholi F, Abuzari N. Effect of eight weeks of continuous and high intensity interval training on UCP1 in visceral and subcutaneous white adipose tissue of obese rats. J Sport Biosciences. 2021;13(4):427-38. doi:10.22059/jsb.2020.301401.1394

23. Farrag M, Ait Eldjoudi D, González-Rodríguez M, Cordero-Barreal A, Ruiz-Fernández C, Capuozzo M, et al. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol. 2023;13:1101091. doi:10.3389/fendo.2022.1101091 PMid:36686442 PMCid:PMC9849689

24. Karbasi S, Zaeemi M, Mohri M, Rashidlamir A, Moosavi Z. Effects of testosterone enanthate and resistance training on myocardium in Wistar rats; clinical and anatomical pathology. J Andrologia. 2018; 50(3): e12908. doi:10.1111/and.12908 PMid:29047154

25. Wang CY, Lin TA, Liu KH, Liao CH, Liu YY, Wu VC, et al. Serum asprosin levels and bariatric surgery outcomes in obese adults. Int J Obes (Lond). 2019; 43(5): 1019-25. doi:10.1038/s41366-018-0248-1 PMid:30459402

26. Wang M, Yin C, Wang L, Liu Y, Li H, Li M, et al. Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity. Ann Nutr Metab. 2019; 75(4): 205-12. doi:10.1159/000503808 PMid:31775140

27. Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, et al. Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017;23(12):1444-53. doi:10.1038/nm.4432 PMid:29106398 PMCid:PMC5720914

28. Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, et al. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion. Mediators Inflamm. 2018;2018:9471583. doi:10.1155/2018/9471583 PMid:29743813 PMCid:PMC5883982

29. Jung TW, Kim HC, Kim HU, Park T, Park J, Kim U, et al. Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle. J Cell Physiol. 2019; 234(11): 20888-99. doi:10.1002/jcp.28694 PMid:30997682

30. Dolataabadi P, Amirsasan R, Vakili J. The effect of high-intensity circuit training on serum asprosin, lipid profile and some fitness factors in overweight and obese women. JAHSSP. 2023; 10(1): 14-26. doi:10.22077/jpsbs.2022.5292.1714

31. Akbulut T, Cinar V, Ugur K, Yardim M, Karagoz ZK, Aydin S. Effect of regular exercise on the levels of subfatin and asprosin: a trial with different types of exercise. Eur Rev Med Pharmacol Sci. 2022; 26(8): 2683-91. doi:10.26355/eurrev_202204_28598

32. Kantorowicz M, Szymura J, Szygula Z, Kusmierczyk J, Maciejczyk M, Wiecek M. Nordic Walking at Maximal Fat Oxidation Intensity Decreases Circulating Asprosin and Visceral Obesity in Women With Metabolic Disorders. Front Physiol. 2021; 12: 726783. doi:10.3389/fphys.2021.726783 PMid:34539448 PMCid:PMC8446531

33. Zarei M, Nakhzari Khodakheyr J, Rashidlamir A, Montazeri A. The effect of combined resistance aerobic exercise training on concentrations of asprosin and complement C1q tumor necrosis factor-related protein-1 in men with type 2 diabetes. Sport Sci Health. 2021:1-9. doi:10.1007/s11332-021-00738-7

34. Jahangiri M, Shahrbanian S, Hackney AC. Changes in the Level of Asprosin as a Novel Adipocytokine after Different Types of Resistance Training. J Chem Health Risks. 2021; 11(Spec Issue): 179-88. doi:10.22034/jchr.2021.1935792.1361

35. Wiecek M, Szymura J, Maciejczyk M, Kantorowicz M, Szygula Z. Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines - A Comparison Between Sexes. Front Physiol. 2018;9: 1782. doi:10.3389/fphys.2018.01782 PMid:30618797 PMCid:PMC6295572

36. Beiter T, Zügel M, Hudemann J, Schild M, Fragasso A, Burgstahler C, et al. The Acute, Short-, and Long-Term Effects of Endurance Exercise on Skeletal Muscle Transcriptome Profiles. Int J Mol Sci. 2024;25(5). doi:10.3390/ijms25052881 PMid:38474128 PMCid:PMC10932090

37. Daneshyar S, Kordi MR, Gaeini A, Kadivar M, Afshari S. The effect of endurance training on gene expression of Uncoupling Protein 1 (UCP-1) in white visceral adipose tissue of retroperitoneal depot of male Wistar rats. Cabidigitallibrary. 2015.

38. Takaishi K, Oshima T, Eto H, Nishihira M, Nguyen ST, Ochi R, et al. Impact of Exercise and Detraining during Childhood on Brown Adipose Tissue Whitening in Obesity. Metabolites. 2021; 11(10). doi:10.3390/metabo11100677 PMid:34677392 PMCid:PMC8540482

39. Khodabandeh M, Peeri M, Azarbayjani MA, Matinhomaee H. The effect of resistance training with liposomal vitamin C on UCP1 and FIS1 expression in hepatocytes of elderly rats Feyz Med Sci J. 2022; 26(1): 22-9. doi:10.48307/FMSJ.2022.26.1.22

40. Khaki E, Dehkordi KJ, Taghian F, Hoseini SA. The effect of eight-week resistance training and consumption of grape seed nanoparticles on mitochondrial biogenesis of heart tissue in the myocardial infarction model. JSUMS. 2022; 24(4): 189-95. doi:10.34172/jsums.2022.31

41. Liu Y, Guo C, Liu S, Zhang S, Mao Y, Fang L. Eight Weeks of High-Intensity Interval Static Strength Training Improves Skeletal Muscle Atrophy and Motor Function in Aged Rats via the PGC-1α/FNDC5/UCP1 Pathway. Clin Interv Aging. 2021;16:811-21. doi:10.2147/CIA.S308893 PMid:34040358 PMCid:PMC8139720

42. Teimourian M, Fatolahi H, Mateenhomaei H. Effect of different exercise mode and ursolic acid supplementation on FNDC5 and UCP1 gene expression and plasma irisin in rats. J Int J Sports Exerc Med. 2020;6(1):160. doi:10.23937/2469-5718/1510160

43. Otero-Díaz B, Rodríguez-Flores M, Sánchez-Muñoz V, Monraz-Preciado F, Ordoñez-Ortega S, Becerril-Elias V, et al. Exercise induces white adipose tissue browning across the weight spectrum in humans. fphys 2018;9:1781. doi:10.3389/fphys.2018.01781 PMid:30618796 PMCid:PMC6297830

44. Reisi J. Effect of 8 weeks resistance training on plasma irisin protein level and muscle FNDC5 and adipose tissue UCP1 genes expression in male rats J Physiol. 2016;7(28):117-30. doi:20.1001.1.2322164.1394.7.28.8.4

45. De Matteis R, Lucertini F, Guescini M, Polidori E, Zeppa S, Stocchi V, et al. Exercise as a new physiological stimulus for brown adipose tissue activity. Nutr Metab Insights. 2013;23(6):582-90.doi:10.1016/j.numecd.2012.01.013 PMid:22633794

46. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. J Nature. 2012; 481(7382): 463-8. doi:10.1038/nature10777 PMid:22237023 PMCid:PMC3522098

47. Nakhuda A, Josse AR, Gburcik V, Crossland H, Raymond F, Metairon S, et al. Biomarkers of browning of white adipose tissue and their regulation during exercise-and diet-induced weight loss. AJCN. 2016;104(3):557-65. doi:10.3945/ajcn.116.132563 PMid:27488235 PMCid:PMC4997298

48. Afshari S, Kordi MR, Mohammad-Amoli M, Daneshyar S. The Effect of High Intensity Interval Training (HIIT) on Gene Expression of Uncoupling Protein 1 (UCP-1) in Subcutaneous White Adipose Tissue of Wistar Rats J Sport Exerc Physiol. 2018; 10(39):17-32. doi:10.22089/spj.2018.1101